FIELD: medicine, pharmaceutical.
SUBSTANCE: invention relates to solid composition for treatment of reflux esophagitis, gastritis, or ulcers, method for production thereof and uses in therapy. Claimed composition contains alginate, bicarbonate and/or carbonate, and poly(C1-C5-alkylene glycol) hawing molecular mass of at least 6000 in amount of 1-50 %.
EFFECT: composition of decreased foam-forming properties and improved organoleptic characteristics.
12 cl, 18 ex
Authors
Dates
2008-02-20—Published
2003-02-07—Filed